Shilpa Medicare

• 

  This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'

  Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.

• 

  Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug

  2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.

• 

  Shilpa Medicare Rallies 26% In Two Days On Tie Up To Make Sputnik Vaccine

  Shilpa Medicare rallied for second straight session on Tuesday after it tied up with Dr Reddy's Labs to make Sputnik V Vaccine.

• 

  Shilpa Medicare Rallies 15% on Quality Certification from Japan

  Shares of Shilpa Medicare rallied as much as 15 per cent to intraday high of Rs 503.65 on Wednesday after the pharmaceutical company said that it has received good manufacturing practices (GMP) compliance certificate for two active pharmaceutical ingredients (API) sites from the Japanese drug regulator.

• 

  Titan Co, Shilpa Medicare Allowed to Raise Foreign Holding

  RBI said, both the companies have passed resolutions at its board of directors level and special resolutions in order to enhance the limit for the purchase of its equity shares and convertible debentures by FIIs/RFPIs.

• Shilpa Medicare hits record high ahead of board meet

  The company, backed by private equity funds Baring Private Equity Partners and Tano Capital, said on Wednesday its board will meet on April 11 to consider a preferential allotment of shares.

• SHILPA MEDICARE LTD. - Board to consider Dividend

  Shilpa Medicare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2011, inter alia, to consider and take on record the following; 1. The Un-audited Financial Results for the quarter enclosed June 30, 2011. 2. The Audited Financial Results for the year ended March 31, 2011. 3. Recommendation of D...

• SHILPA MEDICARE LTD. - Board recommends Dividend

  Shilpa Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2011, inter alia, has decided to recommend dividend @ Rs. 0.80 per equity share of Rs. 2/- each (i.e. 40%) for the financial year ended March 31, 2011 for consideration of shareholders at the ensuing Annual General Meeting.

• SHILPA MEDICARE LTD. - Outcome of Board Meeting

  Shilpa Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2011, have subject to necessary approvals, decided to merge M/s. Raichem Life Sciences Private Limited, a 100% subsidiary of Shilpa Medicare Ltd., with the Company to have cost synergies and other operational benefits.

• Shilpa Medicare gets French nod for oncology manufacturing unit

  MUMBAI, JULY 22: Shilpa Medicare Ltd Wednesday said it has received approval from the French Health Products Safety Agency for manufacturing of gemcitabine hydrochloride at its oncology manufacturing unit located at Deosugar Industrial Area. The latest approval will help the company to market its products in the highly regulated markets of all Eu...

• Shilpa Medicare net profit rises 357.69% in the March 2010 quarter

  Sales rise 54.90% to Rs 61.06 croreNet profit of Shilpa Medicare rose 357.69% to Rs 10.71 crore in the quarter ended March 2010 as against Rs 2.34 crore during the previous quarter ended March 2009. Sales rose 54.90% to Rs 61.06 crore in the quarter ended March 2010 as against Rs 39.42 crore during the previous quarter ended March 2009.For the unau...

• Shilpa Medicare appoints additional director

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Shilpa Medicare appoints additional director

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Shilpa Medicare's director resigns

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Shilpa Medicare net profit rises 1069.44% in the September 2009 quarter

  Sales rise 56.43% to Rs 59.71 croreNet profit of Shilpa Medicare rose 1069.44% to Rs 12.63 crore in the quarter ended September 2009 as against Rs 1.08 crore during the previous quarter ended September 2008. Sales rose 56.43% to Rs 59.71 crore in the quarter ended September 2009 as against Rs 38.17 crore during the previous quarter ended September ...